Non-Pharma Newsletter
Advinus Therapeutics is a leading GLP-certified contract research organization based in India. We offer a whole range of services to fit your regulatory and compliance needs. We have successfully executed numerous GLP-compliant studies following EPA, EEC, OECD and CIPAC guidelines. Our scientific data are of the highest quality and we have a successful track record of completing more than 10,000 GLP studies. Advinus’ focus on quality and timely delivery at competitive prices has established the company as a successful partner and preferred vendor to the world’s largest and fastest growing companies.

Agrochemical Development Services

We offer the following services for agrochemical discovery and development –
  • Synthetic Chemistry
  • Generation of high purity chemical entities for High Throughput Screening (HTS)
  • Well-equipped analytical labs to support isolation and purification of impurities by preparative HPLC, and their analytical characterization using LC-MS, GC-MS, 1H and 13C NMR etc.
  • Process Chemistry
  • Analytical Studies
  • Toxicology testing, including in vitro skin irritation and sensitization (see next section)
REACH (Registration, Evaluation and Authorization of Chemicals) guidelines require industry to ensure that the chemicals it manufactures, imports and puts on the market in EU do not have adverse affect on human health or the environment. Advinus can meet all your physicochemical, toxicity and environmental fate testing needs for REACH registration.

Advinus can help:
  • Determine whether your nutraceutical qualifies as Generally Recognized as Safe (GRAS) Status, and dosing requirements for purified substance vis-à-vis the herbal ingredient
  • Evaluate possibility of abbreviated testing by designing testing strategies that will be acceptable to the agency of choice
  • Design exploratory toxicity and pharmacokinetics studies to address key points of the testing strategy

Advinus has broadened its scope of services through the introduction of in vitro Skin Irritation (OECD 439) and in vitro Skin Corrosion tests (OECD 431). These in vitro tests are performed using the Human 3-Dimensional EpiSkin® test kit. The tests have been validated in our laboratory employing OECD Guideline mandated proficiency substances. The updated OECD guideline for Acute Dermal Irritation/Corrosion (OECD  404) mandates that all chemicals must be evaluated in vitro, prior to testing in animals. These tests are offered both as GLP studies for regulatory submission, and also under non-GLP for screening in the research mode. The in vitro EpiSkin® tests can be taken up in one week following supply of the compound and results can be provided within a week.
Contact us:
Phone: +91-80-2839 4959
21 & 22 Phase II Peenya Industrial Area,
Bangalore 560058, India